Crossmark

Incorporating new evidence on inhaled medications in COPD. The latin American chest association (ALAT) 2019

Crossref DOI link: https://doi.org/10.1016/j.arbr.2019.09.002

Published Print: 2020-02

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Montes de Oca, Maria

Varela, Maria Victorina López

Acuña, Agustín

Schiavi, Eduardo

Casas, Alejandro

Tokumoto, Antonio

Duque, Carlos A. Torres

Ramírez-Venegas, Alejandra

García, Gabriel

Camelier, Aquiles

Bergna, Miguel

Cohen, Mark

Sanchez-Angarita, Efraín

Guzmán, Santiago

Czischke, Karen

Barros, Manuel

Rey, Alejandra
Funding

Funding for this research was provided by:

AstraZeneca

Boehringer Ingelheim

GlaxoSmithKline
License Information

Text and Data Mining valid from 2020-02-01
More Information

This article is maintained by: Elsevier

Article Title: Incorporating new evidence on inhaled medications in COPD. The latin American chest association (ALAT) 2019

Journal Title: Archivos de Bronconeumología (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.arbr.2019.09.002

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.arbres.2019.09.023

Content Type: article

Copyright: © 2019 SEPAR. Published by Elsevier España, S.L.U. All rights reserved.